PT Indofarma Tbk (INAF.JK)

0.0000 -130.0000 (-100.00%) As of 04:00PM WIB. Market open.

PT Indofarma Tbk

Jl. Indofarma No. 1
Cikarang Barat
Bekasi 17530
Indonesia
62 21 8832 3975
https://indofarma.id

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 1,086

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Jejen Nugraha	Production & Supply Chain Director and Director	833.25M	N/A	1980
- Yeliandriani	President Director	N/A	N/A	N/A
Mr. Ariesta Krisnawan	Director of Finance, Risk Management & HR and Director	N/A	N/A	1967
Dr. Andi Prazos Apt, M.M.	Director of Operations & Director	N/A	N/A	1969
Mr. Sigit Prakosa C.A., S.E.	Head of Internal Audit Unit	N/A	N/A	1976
Mr. Warjoko Sumedi	Corporate Secretary	N/A	N/A	1972
Ms. Weny Maulatsih	Secretary of Board of Commissioners	129.01M	N/A	1985

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in IDR.

Description

PT Indofarma Tbk, together with its subsidiaries, engages in the manufacture and sale of pharmaceutical products in Indonesia and internationally. It offers laboratory, pharmaceutical, and health equipment; orthopedic and prosthetic equipment; industrial machinery for packaging, bottling, and canning; provides health consultancy services; and trades in laboratory equipment, pharmacy, and medicines. The company serves medicine product, medical and dental equipment, electromedical and electrotherapy equipment, herbal processing, and tea processing industries, as well as furniture industry for operations, medical care, and dental care. It also engages in marketing, trading, and distribution of products and related activities. The company was formerly known as PT Indofarma (Persero) Tbk. PT Indofarma Tbk was founded in 1918 and is headquartered in Bekasi, Indonesia. PT Indofarma Tbk is a subsidiary of PT Bio Farma.

Corporate governance

PT Indofarma Tbk’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.